Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Emma Jernberg"'
Autor:
Elin Thysell, Linda Vidman, Erik Bovinder Ylitalo, Emma Jernberg, Sead Crnalic, Diego Iglesias‐Gato, Amilcar Flores‐Morales, Pär Stattin, Lars Egevad, Anders Widmark, Patrik Rydén, Anders Bergh, Pernilla Wikström
Publikováno v:
Molecular Oncology, Vol 13, Iss 8, Pp 1763-1777 (2019)
Bone metastasis is the lethal end‐stage of prostate cancer (PC), but the biology of bone metastases is poorly understood. The overall aim of this study was therefore to explore molecular variability in PC bone metastases of potential importance for
Externí odkaz:
https://doaj.org/article/0bd093ff3c7f4e92a8ab6f49ee9111c2
Publikováno v:
Endocrine Connections, Vol 6, Iss 8, Pp 146-161 (2017)
Prostate cancer (PC) remains a leading cause of cancer-related deaths among men worldwide, despite continuously improved treatment strategies. Patients with metastatic disease are treated by androgen deprivation therapy (ADT) that with time results i
Externí odkaz:
https://doaj.org/article/936599725e5b4af7bedd97606bdda062
Autor:
Sofia Halin Bergström, Maria Nilsson, Hanibal Adamo, Elin Thysell, Emma Jernberg, Pär Stattin, Anders Widmark, Pernilla Wikström, Anders Bergh
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0157280 (2016)
Aggressive tumors induce tumor-supporting changes in the benign parts of the prostate. One factor that has increased expression outside prostate tumors is hemoxygenase-1 (HO-1). To investigate HO-1 expression in more detail, we analyzed samples of tu
Externí odkaz:
https://doaj.org/article/90173ad0d3a74cb2b636aa09993af10c
Autor:
Annika Nordstrand, Erik Bovinder Ylitalo, Elin Thysell, Emma Jernberg, Sead Crnalic, Anders Widmark, Anders Bergh, Ulf H. Lerner, Pernilla Wikström
Publikováno v:
International Journal of Molecular Sciences, Vol 19, Iss 4, p 1223 (2018)
Advanced prostate cancer frequently metastasizes to bone and induces a mixed osteoblastic/osteolytic bone response. Standard treatment for metastatic prostate cancer is androgen-deprivation therapy (ADT) that also affects bone biology. Treatment opti
Externí odkaz:
https://doaj.org/article/f80f65344bed462baf795625a89105c8
Autor:
Maria Nilsson, Christina Hägglöf, Peter Hammarsten, Elin Thysell, Pär Stattin, Lars Egevad, Torvald Granfors, Emma Jernberg, Pernilla Wikstrom, Sofia Halin Bergström, Anders Bergh
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0140985 (2015)
Lysyl oxidase (LOX) has been shown to both promote and suppress tumor progression, but its role in prostate cancer is largely unknown. LOX immunoreactivity was scored in prostate tumor epithelium, tumor stroma and in the tumor-adjacent non-malignant
Externí odkaz:
https://doaj.org/article/a3abacd574194e6c88dd8d66a3ef94f0
Autor:
Emma Jernberg, Elin Thysell, Erik Bovinder Ylitalo, Stina Rudolfsson, Sead Crnalic, Anders Widmark, Anders Bergh, Pernilla Wikström
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e77407 (2013)
BACKGROUND: Intra-tumoral steroidogenesis and constitutive androgen receptor (AR) activity have been associated with castration-resistant prostate cancer (CRPC). This study aimed to examine if CRPC bone metastases expressed higher levels of steroid-c
Externí odkaz:
https://doaj.org/article/bab4250ca0174f3b8e2be7442990e889
Autor:
Elin Thysell, Erik Bovinder Ylitalo, Anders Bergh, Emma Jernberg, Sofie Degerman, Sead Crnalic, Pernilla Wikström, Mattias Landfors, Magnus Hultdin, Anders Widmark, Maria Brattsand
Publikováno v:
Clinical Epigenetics
Background Patients with metastatic prostate cancer (PC) are treated with androgen deprivation therapy (ADT) that initially reduces metastasis growth, but after some time lethal castration-resistant PC (CRPC) develops. A better understanding of the t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc80edf0a6395c7899aaf781c6ca1bc0
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-185893
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-185893
Publikováno v:
Endocrine Connections
Endocrine Connections, Vol 6, Iss 8, Pp 146-161 (2017)
Endocrine Connections, Vol 6, Iss 8, Pp 146-161 (2017)
Prostate cancer (PC) remains a leading cause of cancer-related deaths among men worldwide, despite continuously improved treatment strategies. Patients with metastatic disease are treated by androgen deprivation therapy (ADT) that with time results i
Autor:
Erik Djusberg, Anders Widmark, Sead Crnalic, Emma Jernberg, Pia Lundberg, Maria Brattsand, Pernilla Wikström, Anders Bergh, Irina Golovleva, Elin Thysell
Publikováno v:
The Prostate. 77:625-638
BACKGROUND: The relation between androgen receptor (AR) gene amplification and other mechanisms behind castration-resistant prostate cancer (CRPC), such as expression of constitutively active AR va ...
Autor:
Erik Bovinder Ylitalo, Pär Stattin, Sead Crnalic, Patrik Rydén, Lars Egevad, Elin Thysell, Diego Iglesias-Gato, Pernilla Wikström, Linda Vidman, Anders Bergh, Anders Widmark, Emma Jernberg, Amilcar Flores-Morales
Publikováno v:
Molecular Oncology
Molecular Oncology, Vol 13, Iss 8, Pp 1763-1777 (2019)
Molecular Oncology, Vol 13, Iss 8, Pp 1763-1777 (2019)
Bone metastasis is the lethal end‐stage of prostate cancer (PC), but the biology of bone metastases is poorly understood. The overall aim of this study was therefore to explore molecular variability in PC bone metastases of potential importance for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0e6012670f05bf5872cdf985bc95773
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-393124
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-393124